Skip to content

Candel Therapeutics, Inc. CADL Prepaid & Other Current

Prepaid & Other Current at other companies

Amgen logo
AmgenAMGN
$4.11B+26.2%
Gilead Sciences logo
Gilead SciencesGILD
$4.34B+53.5%
Replimune Group logo
Replimune GroupREPL
$8.26M+3.6%
CG Oncology logo
CG OncologyCGON
$23.13M+86.4%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$1.7M+97.6%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$5.74M+20.0%

Other financials

Income statement

See full
Revenue$31.0K0.0%
Operating income-$16.3M-100%
Net income-$8.9M-220%
EPS (diluted)-$0.14-208%

Balance sheet

See full
Cash & equivalents$194.8M+111%
Total debt$2.8M-73.9%
Total equity$138.0M+84.8%
Total assets$201.9M+111%

Cash flow

See full
Operating cash flow-$18.0M-109%
CapEx$675.0K+22,400%
Free cash flow-$18.7M-117%

Valuation

See full
Market cap$693.87M+192%
Enterprise value$501.88M+220%
P/S5,595.7×-18,674×

Profitability

See full
Operating margin-28,000.8%+15,050pp
Net margin-15,156.5%-5,064pp
FCF margin-26,383.9%+14,851pp

Returns & leverage

See full
Return on equity-51.2%-16.6pp
Debt / equity-0.1×
Current ratio28×+23.4×

Where this comes from

Reported directly by Candel Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Candel Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Candel Therapeutics, Inc.'s prepaid & other current?
Candel Therapeutics, Inc. (CADL) reported prepaid & other current of $2.92M in Q1 2026.
How has Candel Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Candel Therapeutics, Inc.'s prepaid & other current increased by 196.8% year-over-year, from $983K to $2.92M.
What is the long-term trend for Candel Therapeutics, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Candel Therapeutics, Inc.'s prepaid & other current has grown at a 77.9% compound annual growth rate (CAGR), from $93K to $1.66M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.